Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-11-001670)

Filing Details

Accession Number:: 0001127602-11-001670
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-01-14 16:23:11
Reporting Period:: 2011-01-11

Filing Date:: 2011-01-14
Accepted Time:: 2011-01-14 16:23:11
Original Submission Date:: 2011-01-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242998	R Jay Lamarche	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-01-11	15,900	$5.50	560,003	No	4	S	Direct
Common Stock	Disposition	2011-01-11	700	$5.51	559,303	No	4	S	Direct
Common Stock	Disposition	2011-01-11	8,400	$5.52	550,903	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2010.
This amendment corrects an error in the price of the Common Stock, as previously reported on Form 4 filed on January 13, 2011.